The global collective intelligence network aims to accelerate precision oncology research and care. Boston, US, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update that several world-renowned healthcare organizations have joined SOPHiA UNITY. SOPHiA UNITY is the global consortium announced at ASCO by SOPHiA […]
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new milestone in the global introduction of the liquid biopsy test MSK-ACCESS® powered with SOPHiA DDM™, first announced […]
Cloud-based CodeXome offers a unique opportunity to study gene function and evolution across species FREDERICK, Md. — Cornerstone Genomics, a pioneer in advanced genomic research software, proudly announces the launch of CodeXome, a groundbreaking all-in-one platform designed to accelerate the discovery of genetic targets by providing researchers with extensive cross-species data. Tailored for genome scientists in academia, […]
Boston, US, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update from the Company’s work with biopharma company Boundless Bio. SOPHiA GENETICS first partnered with Boundless Bio in 2022 to develop and deploy Boundless Bio’s extrachromosomal DNA (ecDNA) detection algorithm as a […]
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education NEW YORK — BioAro successfully launched its presence in the UK at the Royal Society on August 29th, 2024. BioAro’s UK launch marks a significant step in the company’s mission to revolutionize precision medicine. Leveraging advanced AI-driven genomic analysis, […]
Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. The new-gen SOPHiA DDM™ Platform offers a new architecture designed to more efficiently compute large amounts of data at-scale, while elevating customer experience with […]
BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets […]
Boston, US and Rolle, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA […]
MOUNTAIN VIEW, Calif., and MIAMI LAKES, Fla. — DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to ‘Precision Health at Scale for All,’ today announced a strategic collaboration to enhance biomedical research and precision medicine, particularly for Latin American populations and other underserved groups. The collaboration will combine Galatea’s specialized […]
Bioinformatics — We are excited to announce the release of OmicsBox 3.3, the All-In-One bioinformatics software, designed to simplify your research. This latest version integrates a range of new features and improvements, offering improved usability, advanced functionalities, and expanded database support to meet the diverse needs of the bioinformatics community. With a focus on providing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
